HeartSciences Inc. (HSCS)
NASDAQ: HSCS · Real-Time Price · USD
2.640
-0.090 (-3.30%)
Nov 20, 2024, 4:00 PM EST - Market closed
HeartSciences Employees
HeartSciences had 15 employees as of April 30, 2024. The number of employees increased by 3 or 25.00% compared to the previous year.
Employees
15
Change (1Y)
3
Growth (1Y)
25.00%
Revenue / Employee
$1,240
Profits / Employee
-$486,003
Market Cap
2.41M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Apr 30, 2024 | 15 | 3 | 25.00% |
| Apr 30, 2023 | 12 | 0 | - |
| Apr 30, 2022 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Xylo Technologies | 84 |
| Avinger | 72 |
| Nuwellis | 59 |
| Scinai Immunotherapeutics | 31 |
| ReShape Lifesciences | 29 |
| Petros Pharmaceuticals | 21 |
| Biodexa Pharmaceuticals | 21 |
| PainReform | 7 |
HSCS News
- 8 days ago - HeartSciences' AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement - GlobeNewsWire
- 5 weeks ago - HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit - GlobeNewsWire
- 2 months ago - HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results - GlobeNewsWire
- 2 months ago - HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission - GlobeNewsWire
- 4 months ago - HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results - GlobeNewsWire
- 4 months ago - Innovation Value Institute Analysis Demonstrates HeartSciences' MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency - GlobeNewsWire
- 4 months ago - HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare - GlobeNewsWire
- 4 months ago - HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction - GlobeNewsWire